Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
CJS Securities analyst Christopher Moore initiates coverage on Mirion Technologies (NYSE:MIR) with a Market Outperform rating and announces Price Target of $13.